 |
Frederic
I. Preffer, Ph.D.
Associate Professor of Pathology
Harvard Medical School
Department of Pathology
Office:
Center for Regenerative Medicine and Technology
Charles River Plaza North, 4-226
185 Cambridge St, Boston, MA 02114
Clinical Lab:
Warren 112
Massachusetts General Hospital
Boston, MA, 02114
Phone: 617-726-7481
Fax: 617-724-3164
Email:
preffer@helix.mgh.harvard.edu
|
A
stem cell has the unique capacity to both self-renew
and to give rise to specialized cells. Until recently
it was believed that only embryonic stem cells were
pluripotent and only they could give rise to committed
cells of various different tissues with different
function. Over the past few years, it has become apparent
that stem cells derived from differentiated adult
tissue may also develop into mature cell types of
disparate tissue. Hematopoietic stem cells are characteristically
quiescent, multipotent cells with both the capacity
for self-renewal and differentiation. After development
in the fetus, these cells reside in adult bone marrow
and serve to replenish lymphoid, megakaryocytic, erythroid
and myeloid hematopoietic lineages throughout the
lifetime of the host. Early investigations in this
laboratory discerned that cells obtained from adult
blood within a CD3-7+ lymphocyte compartment could
develop predominantly in vitro into mature gamma delta+
T cells. Later studies fine-tuned this compartment
into CD7+/CD7- and CD16+/CD16- divisions. Of particular
present interest are side population [SP] cells, which
are relatively rare cells found in both the circulation
and bone marrow. These CD34 negative cells, when isolated
from human blood, have been shown to be capable of
developing into T, NK and possibly dendritic cells.
Other interests in the laboratory involve
the study of patients administered HLA mismatched
transplants, done in collaboration with the Transplantation
Biology Research Center and Bone Marrow Transplantation
Units. The goal of these studies is to establish a
state of mixed chimerism in patients with hematologic
malignancies, so as to provide a minimum of graft
vs. host and a maximum of graft vs. leukemia effects.
Additionally, our laboratory participates in numerous
projects with the CNY AIDS Research Center and Harvard
Medical School Center for AIDS Research [CFAR].
The flow cytometry laboratory in the Center for Regenerative
Medicine is a valuable hospital core resource, and
will entertain research collaborations from throughout
the university. The laboratory contains a state-of-the-art
5-laser DiVa cell sorter and 7-laser LSR-2. The cell
sorter has 11 photomultiplier tubes and is capable
of 4-way high speed cell sorting. The numerous laser
excitation lines and photomultiplier capacity provides
a wide breadth of capability to the instrument, which
is superbly operated by Mr. David Dombkowski. The
research laboratory was the genesis of the clinical
laboratory, which is located on Warren 1 on the MGH
campus in Boston. Four- and six-color analytic instrumentation
[FACSCalibur, FACSCanto] is available at that site.
|